Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer

被引：1
|
作者：
Arora, Ritu [1 ]
Gary, Bernard D. [1 ]
McClellan, Steven [1 ]
Xi, Yaguang [1 ]
Piazza, Gary [1 ]
Reed, Eddie [1 ]
Owen, Laurie [1 ]
Dean-Colomb, Windy [1 ]
机构：
[1] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-5571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5571
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Bromodomain Proteins as Novel Therapeutic Targets in Triple Negative Breast Cancer
    You, Yuan
    Rossi, Michael J.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2017, 53 (07) : 662 - 662
  • [22] A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells
    Fouque, Amelie
    Delalande, Olivier
    Jean, Mickael
    Castellano, Remy
    Josselin, Emmanuelle
    Malleter, Marine
    Shoji, Kenji F.
    Mac Dinh Hung
    Rampanarivo, Hariniaina
    Collette, Yves
    van de Weghe, Pierre
    Legembre, Patrick
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (16) : 6559 - 6573
  • [23] Isolation Of Natural Products With Selective Cytotoxic Activity Against Triple-Negative Breast Cancer Subtypes
    Robles, A. J.
    Cai, S.
    King, J.
    Cichewicz, R. H.
    Mooberry, S. L.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [24] Identification of natural products with selective activity against triple-negative breast cancer molecular subtypes
    Robles, A. J.
    Du, L.
    Cai, S.
    King, J. B.
    Cichewicz, R. H.
    Mooberry, S. L.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [25] Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
    Dolores Cuenca-Lopez, Maria
    Serrano-Heras, Gemma
    Carlos Montero, Juan
    Corrales-Sanchez, Veronica
    Gomez-Juarez, Monica
    Jose Gascon-Escribano, Maria
    Carlos Morales, Jorge
    Voisin, Veronique
    Elena Nunez, Luz
    Moris, Francisco
    Bader, Gary D.
    Pandiella, Atanasio
    Ocana, Alberto
    ONCOTARGET, 2015, 6 (29) : 27923 - 27937
  • [26] Preclinical antitumor activity of novel small molecule glutaminase inhibitors in triple-negative breast cancer.
    Demo, Susan
    Chernov-Rogan, Tania
    Gross, Matthew
    Janes, Julie
    Kawas, Raja
    Lewis, Evan
    Parlati, Francesco
    Rodriguez, Hector
    Rodriguez, Mirna
    Yang, Jinfu
    Zhao, Frances
    Richardson, Adam
    Bennett, Mark K.
    CANCER RESEARCH, 2013, 73 (08)
  • [27] Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
    Srivastava, Nityanand
    Usmani, Salman Sadullah
    Subbarayan, Rajasekaran
    Saini, Rashmi
    Pandey, Pranav Kumar
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Combination therapeutic strategy to fight against triple-negative breast cancer
    Svajda, Laura
    Randelovic, Ivan
    Surguta, Sara Eszter
    Baranyi, Marcell
    Kenessey, Istvan
    Cserepes, Mihaly
    Tovari, Jozsef
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Therapeutic targets in triple negative breast cancer
    O'Toole, Sandra A.
    Beith, Jane M.
    Millar, Ewan K. A.
    West, Richard
    McLean, Anna
    Cazet, Aurelie
    Swarbrick, Alexander
    Oakes, Samantha R.
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (06) : 530 - 542
  • [30] Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases
    Kai, Kazuharu
    Kondo, Kimie
    Wang, Xiaoping
    Xie, Xuemei
    Pitner, Mary K.
    Reyes, Monica E.
    Torres-Adorno, Angie M.
    Masuda, Hiroko
    Hortobagyi, Gabriel N.
    Bartholomeusz, Chandra
    Saya, Hideyuki
    Tripathy, Debu
    Sen, Subrata
    Ueno, Naoto T.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (12) : 2687 - 2699
12345